Sultopride (BioDeep_00000408930)

Main id: BioDeep_00000008819

 


代谢物信息卡片


Sultopride

化学式: C17H26N2O4S (354.1613)
中文名称: 舒托必利
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CCN(C2)C(CC2)CNC(=O)c(c(OC)1)cc(cc1)S(=O)(=O)CC
InChI: InChI=1S/C17H26N2O4S/c1-4-19-10-6-7-13(19)12-18-17(20)15-11-14(24(21,22)5-2)8-9-16(15)23-3/h8-9,11,13H,4-7,10,12H2,1-3H3,(H,18,20)

描述信息

D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents
D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents
D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents
D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants
N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AL - Benzamides
C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent
Same as: D08549

同义名列表

2 个代谢物同义名

Sultopride; Sultopride



数据库引用编号

17 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。

亚细胞结构定位 关联基因列表
Cytoplasm 8 ABCB1, ADRA1A, AHR, ALB, AXIN2, CASP1, IL18, NLRP3
Endoplasmic reticulum membrane 2 CD4, DRD1
Nucleus 7 ADRA1A, AHR, ALB, AXIN2, DRD1, FOS, NLRP3
cytosol 8 ADRA1A, AHR, ALB, AXIN2, CASP1, FOS, IL18, NLRP3
dendrite 2 DRD2, PDYN
centrosome 2 ALB, AXIN2
nucleoplasm 3 ADRA1A, AHR, FOS
RNA polymerase II transcription regulator complex 1 FOS
Cell membrane 9 ABCB1, ADRA1A, CASP1, CD4, DRD1, DRD2, OPRD1, SLCO1A2, TNF
Multi-pass membrane protein 7 ABCB1, ABCC3, ADRA1A, DRD1, DRD2, OPRD1, SLCO1A2
Golgi apparatus membrane 2 DRD2, NLRP3
Synapse 3 DRD2, PDYN, TAC1
cell surface 2 ABCB1, TNF
glutamatergic synapse 2 DRD1, DRD2
Golgi apparatus 1 ALB
Golgi membrane 3 DRD2, INS, NLRP3
neuronal cell body 3 PDYN, TAC1, TNF
presynaptic membrane 3 DRD1, DRD2, OPRD1
Cytoplasm, cytosol 2 IL18, NLRP3
acrosomal vesicle 1 DRD2
plasma membrane 12 ABCB1, ABCC3, ADRA1A, AXIN2, CASP1, CD4, DRD1, DRD2, OPRD1, PDYN, SLCO1A2, TNF
synaptic vesicle membrane 2 DRD2, OPRD1
Membrane 5 ABCB1, ABCC3, NLRP3, OPRD1, SLCO1A2
apical plasma membrane 2 ABCB1, SLCO1A2
axon 2 DRD2, TAC1
basolateral plasma membrane 2 ABCC3, SLCO1A2
caveola 1 ADRA1A
extracellular exosome 2 ABCB1, ALB
endoplasmic reticulum 3 ALB, FOS, NLRP3
extracellular space 6 ALB, IL18, IL6, INS, TAC1, TNF
mitochondrion 1 NLRP3
protein-containing complex 3 AHR, ALB, CASP1
intracellular membrane-bounded organelle 1 ADRA1A
Single-pass type I membrane protein 1 CD4
Secreted 6 ALB, IL18, IL6, INS, NLRP3, PDYN
extracellular region 8 ALB, IL18, IL6, INS, NLRP3, PDYN, TAC1, TNF
hippocampal mossy fiber to CA3 synapse 1 PDYN
anchoring junction 1 ALB
transcription regulator complex 1 AHR
ciliary membrane 2 DRD1, DRD2
Nucleus membrane 1 ADRA1A
nuclear membrane 1 ADRA1A
external side of plasma membrane 2 CD4, TNF
dendritic spine 2 DRD1, DRD2
perikaryon 1 DRD2
beta-catenin destruction complex 1 AXIN2
nucleolus 1 CASP1
Early endosome 1 CD4
recycling endosome 1 TNF
Single-pass type II membrane protein 1 TNF
postsynaptic membrane 2 DRD1, DRD2
Apical cell membrane 1 ABCB1
Membrane raft 2 CD4, TNF
microtubule 1 CASP1
GABA-ergic synapse 2 DRD1, DRD2
Cell projection, dendritic spine 1 DRD1
lateral plasma membrane 1 DRD2
Cytoplasm, cytoskeleton, microtubule organizing center 1 NLRP3
Inflammasome 1 NLRP3
interphase microtubule organizing center 1 NLRP3
NLRP3 inflammasome complex 2 CASP1, NLRP3
neuron projection 1 OPRD1
ciliary basal body 1 ALB
cilium 2 DRD1, DRD2
chromatin 2 AHR, FOS
phagocytic cup 1 TNF
centriole 1 ALB
spindle pole 1 ALB
blood microparticle 1 ALB
non-motile cilium 2 DRD1, DRD2
Basolateral cell membrane 1 ABCC3
sperm flagellum 1 DRD2
Endomembrane system 1 NLRP3
endosome lumen 1 INS
Membrane, caveola 1 ADRA1A
microtubule organizing center 1 NLRP3
aryl hydrocarbon receptor complex 1 AHR
Cell projection, dendrite 1 DRD1
basal plasma membrane 2 ABCC3, SLCO1A2
secretory granule lumen 1 INS
Golgi lumen 1 INS
endoplasmic reticulum lumen 4 ALB, CD4, IL6, INS
nuclear matrix 1 FOS
platelet alpha granule lumen 1 ALB
axon terminus 3 DRD2, OPRD1, PDYN
endocytic vesicle 1 DRD2
transport vesicle 1 INS
Endoplasmic reticulum-Golgi intermediate compartment membrane 1 INS
postsynaptic density membrane 1 OPRD1
neuronal dense core vesicle 2 OPRD1, PDYN
AIM2 inflammasome complex 1 CASP1
clathrin-coated endocytic vesicle membrane 1 CD4
Basal cell membrane 2 ABCC3, SLCO1A2
protein-DNA complex 1 FOS
external side of apical plasma membrane 1 ABCB1
canonical inflammasome complex 1 CASP1
dopaminergic synapse 1 DRD2
dendrite membrane 1 OPRD1
Cell projection, cilium membrane 1 DRD1
transcription factor AP-1 complex 1 FOS
[Tumor necrosis factor, soluble form]: Secreted 1 TNF
T cell receptor complex 1 CD4
interleukin-6 receptor complex 1 IL6
G protein-coupled receptor complex 2 DRD1, DRD2
nuclear aryl hydrocarbon receptor complex 1 AHR
IPAF inflammasome complex 1 CASP1
NLRP1 inflammasome complex 1 CASP1
protease inhibitor complex 1 CASP1
cytosolic aryl hydrocarbon receptor complex 1 AHR
spine apparatus 1 OPRD1
ciliary transition fiber 1 ALB
[C-domain 2]: Secreted 1 TNF
[Tumor necrosis factor, membrane form]: Membrane 1 TNF
[C-domain 1]: Secreted 1 TNF


文献列表

  • Jingda Cai, Li Li, Tiannan Shao, Mengxi Sun, Weiyan Wang, Peng Xie, Xiaoyi Wang, Ye Yang, Yujun Long, Dongyu Kang, Jingmei Xiao, Yuhan Su, Xingjie Peng, Yuyan Huang, Menghui Gao, Qiongqiong Wu, Chuhan Song, Furu Liu, Ping Shao, Jianjun Ou, Yidong Shen, Jing Huang, Renrong Wu. Relapse in patients with schizophrenia and amisulpride-induced hyperprolactinemia or olanzapine-induced metabolic disturbance after switching to other antipsychotics. Psychiatry research. 2023 Mar; 322(?):115138. doi: 10.1016/j.psychres.2023.115138. [PMID: 36871411]
  • Hae-Jung Yang, Seung-Gon Kim, Eun Hyun Seo, Hyung-Jun Yoon. Amisulpride withdrawal akathisia responding to aripiprazole with propranolol in first-onset psychosis: a case report. BMC psychiatry. 2022 01; 22(1):74. doi: 10.1186/s12888-022-03721-9. [PMID: 35093063]
  • Bozhi Yuan, Mei Yuan. Changes of Mental State and Serum Prolactin Levels in Patients with Schizophrenia and Depression after Receiving the Combination Therapy of Amisulpride and Chloroprothixol Tablets. Computational and mathematical methods in medicine. 2022; 2022(?):6580030. doi: 10.1155/2022/6580030. [PMID: 35242209]
  • Jinchi Zheng, Zeya Lin, Chih-Yuan Ko, Jian-Hua Xu, Yichuan Lin, Jinyi Wang. Analysis of Gut Microbiota in Patients with Exacerbated Symptoms of Schizophrenia following Therapy with Amisulpride: A Pilot Study. Behavioural neurology. 2022; 2022(?):4262094. doi: 10.1155/2022/4262094. [PMID: 35287288]
  • Kankan Qu, Feng Wang, Zhiqiang Du, Shushan Wang, Zhongdong Zhang, Yuan Shen. A novel and sensitive method for determination of amisulpride in human plasma by two-dimensional liquid chromatography. Biomedical chromatography : BMC. 2021 Oct; 35(10):e5149. doi: 10.1002/bmc.5149. [PMID: 33928659]
  • Daniel A Hussar. New Drugs 2021, Part 2. Nursing. 2021 Oct; 51(10):18-29. doi: 10.1097/01.nurse.0000791756.56705.dd. [PMID: 34580258]
  • Dnyandev Gadhave, Shrikant Tupe, Amol Tagalpallewar, Bapi Gorain, Hira Choudhury, Chandrakant Kokare. Nose-to-brain delivery of amisulpride-loaded lipid-based poloxamer-gellan gum nanoemulgel: In vitro and in vivo pharmacological studies. International journal of pharmaceutics. 2021 Sep; 607(?):121050. doi: 10.1016/j.ijpharm.2021.121050. [PMID: 34454028]
  • Fengli Sun, Fang Yu, Zhihan Gao, Zhibin Ren, Weidong Jin. Study on the relationship among dose, concentration and clinical response in Chinese schizophrenic patients treated with Amisulpride. Asian journal of psychiatry. 2021 Aug; 62(?):102694. doi: 10.1016/j.ajp.2021.102694. [PMID: 34052710]
  • Fenglin Wang, Sandong Yang, Xinying Zhou, Jiao Feng, Tao Tang, Tong Li. [Integrated multi-column two-dimensional liquid chromatographic system for determination of amisulpride in serum]. Se pu = Chinese journal of chromatography. 2021 Feb; 39(2):197-202. doi: 10.3724/sp.j.1123.2020.07035. [PMID: 34227352]
  • Shanqing Huang, Lu Li, Zhanzhang Wang, Tao Xiao, Xiaolin Li, Shujing Liu, Ming Zhang, Haoyang Lu, Yuguan Wen, Dewei Shang. Modeling and Simulation for Individualized Therapy of Amisulpride in Chinese Patients with Schizophrenia: Focus on Interindividual Variability, Therapeutic Reference Range and the Laboratory Alert Level. Drug design, development and therapy. 2021; 15(?):3903-3913. doi: 10.2147/dddt.s327506. [PMID: 34548782]
  • Erik Johnsen, Rune A Kroken, Else-Marie Løberg, Maria Rettenbacher, Inge Joa, Tor Ketil Larsen, Solveig Klæbo Reitan, Berit Walla, Renata Alisauskiene, Liss Gøril Anda, Christoffer Bartz-Johannessen, Jan Øystein Berle, Jill Bjarke, Farivar Fathian, Kenneth Hugdahl, Eirik Kjelby, Igne Sinkeviciute, Silje Skrede, Lena Stabell, Vidar M Steen, W Wolfgang Fleischhacker. Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial. The lancet. Psychiatry. 2020 11; 7(11):945-954. doi: 10.1016/s2215-0366(20)30341-2. [PMID: 33069317]
  • Binbin Chen, Chen Wang, Xiangzhen Xu, Haiyan Lyu, Chunling Ma, Gang Cheng. Risk of Prolonged Corrected QT Interval With Amisulpride Therapy for Renal Function Management in Patients With Schizophrenia. Journal of clinical psychopharmacology. 2020 Sep; 40(5):482-486. doi: 10.1097/jcp.0000000000001257. [PMID: 32826486]
  • Eleftheria Kopelli, Myrto Samara, Antonios Siargkas, Antonis Goulas, Georgios Papazisis, Michail Chourdakis. The role of cannabidiol oil in schizophrenia treatment. a systematic review and meta-analysis. Psychiatry research. 2020 09; 291(?):113246. doi: 10.1016/j.psychres.2020.113246. [PMID: 32599446]
  • Noha N Atia, Mostafa A Marzouq, Ahmed I Hassan, Walid E Eltoukhi. A rapid FTIR spectroscopic assay for quantitative determination of Memantine hydrochloride and Amisulpride in human plasma and pharmaceutical formulations. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy. 2020 Aug; 236(?):118377. doi: 10.1016/j.saa.2020.118377. [PMID: 32330826]
  • Lin Li, Lu Li, De-Wei Shang, Yu-Guan Wen, Yu-Ping Ning. A systematic review and combined meta-analysis of concentration of oral amisulpride. British journal of clinical pharmacology. 2020 04; 86(4):668-678. doi: 10.1111/bcp.14246. [PMID: 32090363]
  • Noha N Atia, Mostafa A Marzouq, Ahmed I Hassan, Walid E Eltoukhi. A new spectrofluorimetric assay for quantification of Amisulpride and Memantine hydrochloride in real human plasma sample and pharmaceutical formulations via Hantzsch reaction. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy. 2020 Jan; 224(?):117388. doi: 10.1016/j.saa.2019.117388. [PMID: 31357052]
  • Gayathri Nair Sekhar, Alice L Fleckney, Sevda Tomova Boyanova, Huzefa Rupawala, Rachel Lo, Hao Wang, Doaa B Farag, Khondaker Miraz Rahman, Martin Broadstock, Suzanne Reeves, Sarah Ann Thomas. Region-specific blood-brain barrier transporter changes leads to increased sensitivity to amisulpride in Alzheimer's disease. Fluids and barriers of the CNS. 2019 Dec; 16(1):38. doi: 10.1186/s12987-019-0158-1. [PMID: 31842924]
  • Noha N Atia, Mostafa A Marzouq, Ahmed I Hassan, Walid E Eltoukhi. A new sensitive approach for spectrofluorimetric assay of Milnacipran and Amisulpride in real plasma and pharmaceutical preparations via complexation with Eosin Y dye. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy. 2019 May; 214(?):399-406. doi: 10.1016/j.saa.2019.02.071. [PMID: 30802797]
  • Signe W Düring, Mette Ø Nielsen, Nikolaj Bak, Birte Y Glenthøj, Bjørn H Ebdrup. Sexual dysfunction and hyperprolactinemia in schizophrenia before and after six weeks of D2/3 receptor blockade - An exploratory study. Psychiatry research. 2019 04; 274(?):58-65. doi: 10.1016/j.psychres.2019.02.017. [PMID: 30780063]
  • Abd El-Halim I El Assasy, Niha F Younes, Amal I A Makhlouf. Enhanced Oral Absorption of Amisulpride Via a Nanostructured Lipid Carrier-Based Capsules: Development, Optimization Applying the Desirability Function Approach and In Vivo Pharmacokinetic Study. AAPS PharmSciTech. 2019 Jan; 20(2):82. doi: 10.1208/s12249-018-1283-x. [PMID: 30652198]
  • Prajapati Jagruti B, Sawant Krutika K, Bhramanand Dubey. Oral Bioavailability Enhancement of Amisulpride: Complexation and its Pharmacokinetics and Pharmacodynamics Evaluations. Drug metabolism letters. 2019; 13(2):132-144. doi: 10.2174/1872312813666191018152226. [PMID: 31975684]
  • Marwa H Shukr, Omar A Ahmed Farid. Amisulpride-CD-Loaded Liposomes: Optimization and In Vivo Evaluation. AAPS PharmSciTech. 2018 Aug; 19(6):2658-2671. doi: 10.1208/s12249-018-1079-z. [PMID: 29943282]
  • Si-Si Cao, Yan-Xia Ma, Ping-Fei Fang, Hua-Lin Cai, Yang Deng, Zhen-Yan Hou, Ying Chen, Miao Yan, Bi-Kui Zhang. Pharmacokinetics and relative bioavailability of a generic amisulpride tablet in healthy Chinese volunteers
. International journal of clinical pharmacology and therapeutics. 2017 Oct; 55(10):825-831. doi: 10.5414/cp203000. [PMID: 28793958]
  • Teng Wang, Yajun Zheng, Xiaoting Wang, Daniel E Austin, Zhiping Zhang. Sub-ppt Mass Spectrometric Detection of Therapeutic Drugs in Complex Biological Matrixes Using Polystyrene-Microsphere-Coated Paper Spray. Analytical chemistry. 2017 08; 89(15):7988-7995. doi: 10.1021/acs.analchem.7b01296. [PMID: 28686424]
  • Piotr Skrobecki, Anna Chmielińska, Piotr Bonarek, Piotr Stepien, Anna Wisniewska-Becker, Marta Dziedzicka-Wasylewska, Agnieszka Polit. Sulpiride, Amisulpride, Thioridazine, and Olanzapine: Interaction with Model Membranes. Thermodynamic and Structural Aspects. ACS chemical neuroscience. 2017 07; 8(7):1543-1553. doi: 10.1021/acschemneuro.7b00057. [PMID: 28375612]
  • Li-Juan Gao, Hua-Gui Guo, Zhen-Tao Liang, Xiao-Xiao Zhong, Jin-Cai Zhu, Yu Yang. [Aripiprazole for drug-induced sexual dysfunction in schizophrenic males]. Zhonghua nan ke xue = National journal of andrology. 2017 Jul; 23(7):615-619. doi: NULL. [PMID: 29723454]
  • Danielle S Fisher, Chad Beyer, Gerrit van Schalkwyk, Soraya Seedat, Robert J Flanagan. Measurement of Clozapine, Norclozapine, and Amisulpride in Plasma and in Oral Fluid Obtained Using 2 Different Sampling Systems. Therapeutic drug monitoring. 2017 04; 39(2):109-117. doi: 10.1097/ftd.0000000000000377. [PMID: 28125503]
  • Jörg Täubel, Georg Ferber, Gabriel Fox, Sara Fernandes, Ulrike Lorch, A John Camm. Thorough QT study of the effect of intravenous amisulpride on QTc interval in Caucasian and Japanese healthy subjects. British journal of clinical pharmacology. 2017 02; 83(2):339-348. doi: 10.1111/bcp.13128. [PMID: 27618796]
  • Alper Bas, Gozde Gultekin, Said Incir, Tuba Ocek Bas, Murat Emul, Alaatin Duran. Level of serum thioredoxin and correlation with neurocognitive functions in patients with schizophrenia using clozapine and other atypical antipsychotics. Psychiatry research. 2017 Jan; 247(?):84-89. doi: 10.1016/j.psychres.2016.11.021. [PMID: 27871032]
  • Sean J OʼHalloran, Antonia Wong, David A Joyce. A Liquid Chromatography-Tandem Mass Spectrometry Method for Quantifying Amisulpride in Human Plasma and Breast Milk, Applied to Measuring Drug Transfer to a Fully Breast-Fed Neonate. Therapeutic drug monitoring. 2016 08; 38(4):493-8. doi: 10.1097/ftd.0000000000000300. [PMID: 27027463]
  • Chun-Yen Chen, Yi-Wei Yeh, Shin-Chang Kuo, Pei-Shen Ho, Chih-Sung Liang, Che-Hung Yen, Ru-Band Lu, San-Yuan Huang. Catechol-O-methyltransferase gene variants may associate with negative symptom response and plasma concentrations of prolactin in schizophrenia after amisulpride treatment. Psychoneuroendocrinology. 2016 Mar; 65(?):67-75. doi: 10.1016/j.psyneuen.2015.12.003. [PMID: 26724569]
  • Mucahit Avcil, Mucahit Kapçı, Irfan Yavaşoğlu, Burçak Kantekin, Mahmut Akpek. Simultaneous Use of Intravenous Lipid Emulsion and Plasma Exchange Therapies in Multiple Drug Toxicity. Medical principles and practice : international journal of the Kuwait University, Health Science Centre. 2016; 25(6):577-579. doi: 10.1159/000449250. [PMID: 27548660]
  • Ying Liang, Yun-Ai Su, Zhen-Guo Zhao, Nan Gao, Ji-Zhong Huang, Mao-Qin Tang, Ke-Qing Li, Fu-De Yang, Xin Yu, Tian-Mei Si. Acute Effects of Haloperidol, Amisulpride, and Quetiapine on Bone Turnover Markers in Patients With Schizophrenia. Journal of clinical psychopharmacology. 2015 Oct; 35(5):583-6. doi: 10.1097/jcp.0000000000000379. [PMID: 26270200]
  • Coraline D Metzger, Maike Wiegers, Martin Walter, Birgit Abler, Heiko Graf. Local and Global Resting State Activity in the Noradrenergic and Dopaminergic Pathway Modulated by Reboxetine and Amisulpride in Healthy Subjects. The international journal of neuropsychopharmacology. 2015 Jul; 19(2):. doi: 10.1093/ijnp/pyv080. [PMID: 26209860]
  • Keumhan Noh, Yoo-Jeong Jang, Kwang-il Kwon, Eunyoung Kim, Tae Cheon Jeong, Hwi-yeol Yun, Wonku Kang. Quantitative determination of amisulpride in rat plasma by HPLC-MS/MS. Archives of pharmacal research. 2015 Jan; 38(1):63-7. doi: 10.1007/s12272-014-0361-1. [PMID: 24619919]
  • Joao N Dos Santos Pereira, Sina Tadjerpisheh, Manar Abu Abed, Ali R Saadatmand, Babette Weksler, Ignacio A Romero, Pierre-Olivier Couraud, Jürgen Brockmöller, Mladen V Tzvetkov. The poorly membrane permeable antipsychotic drugs amisulpride and sulpiride are substrates of the organic cation transporters from the SLC22 family. The AAPS journal. 2014 Nov; 16(6):1247-58. doi: 10.1208/s12248-014-9649-9. [PMID: 25155823]
  • Yoo-Jung Jang, Tae Cheon Jeong, Keumhan Noh, In-Whan Baek, Kwang-il Kwon, Eunyoung Kim, Young-Ran Yoon, Wonku Kang. Prandial effect on the systemic exposure of amisulpride. Archives of pharmacal research. 2014 Oct; 37(10):1325-8. doi: 10.1007/s12272-014-0331-7. [PMID: 24469600]
  • Danielle S Fisher, Suzanne J Partridge, Simon A Handley, Robert J Flanagan. Stability of some atypical antipsychotics in human plasma, haemolysed whole blood, oral fluid, human serum and calf serum. Forensic science international. 2013 Jun; 229(1-3):151-6. doi: 10.1016/j.forsciint.2013.03.021. [PMID: 23570966]
  • Danielle S Fisher, Suzanne J Partridge, Simon A Handley, Lewis Couchman, Phillip E Morgan, Robert J Flanagan. LC-MS/MS of some atypical antipsychotics in human plasma, serum, oral fluid and haemolysed whole blood. Forensic science international. 2013 Jun; 229(1-3):145-50. doi: 10.1016/j.forsciint.2013.02.010. [PMID: 23477803]
  • M A Birch, L Couchman, S Pietromartire, T Karna, C Paton, R McAllister, A Marsh, R J Flanagan. False-positive buprenorphine by CEDIA in patients prescribed amisulpride or sulpiride. Journal of analytical toxicology. 2013 May; 37(4):233-6. doi: 10.1093/jat/bkt016. [PMID: 23471956]
  • Marie Bicikova, Martin Hill, Daniela Ripova, Pavel Mohr, Richard Hampl. Determination of steroid metabolome as a possible tool for laboratory diagnosis of schizophrenia. The Journal of steroid biochemistry and molecular biology. 2013 Jan; 133(?):77-83. doi: 10.1016/j.jsbmb.2012.08.009. [PMID: 22944140]
  • David N Osser, Mohsen Jalali Roudsari, Theo Manschreck. The psychopharmacology algorithm project at the Harvard South Shore Program: an update on schizophrenia. Harvard review of psychiatry. 2013 Jan; 21(1):18-40. doi: 10.1097/hrp.0b013e31827fd915. [PMID: 23656760]
  • Sally V J Bowskill, Maxine X Patel, Simon A Handley, Robert J Flanagan. Plasma amisulpride in relation to prescribed dose, clozapine augmentation, and other factors: data from a therapeutic drug monitoring service, 2002-2010. Human psychopharmacology. 2012 Sep; 27(5):507-13. doi: 10.1002/hup.2256. [PMID: 22996618]
  • Hyun-Ghang Jeong, Moon-Soo Lee, Hwa-Young Lee, Young-Hoon Ko, Changsu Han, Sook-Haeng Joe. Changes in sexual function and gonadal axis hormones after switching to aripiprazole in male schizophrenia patients: a prospective pilot study. International clinical psychopharmacology. 2012 Jul; 27(4):177-83. doi: 10.1097/yic.0b013e328351c8c4. [PMID: 22407277]
  • Bun-Hee Lee, Seung-Gul Kang, Tae-Woo Kim, Heon-Jeong Lee, Ho-Kyoung Yoon, Young-Min Park. Hyperprolactinemia induced by low-dosage amisulpride in Korean psychiatric patients. Psychiatry and clinical neurosciences. 2012 Feb; 66(1):69-73. doi: 10.1111/j.1440-1819.2011.02296.x. [PMID: 22250612]
  • L Couchman, P E Morgan, R J Flanagan. Basic drug analysis by strong cation-exchange liquid chromatography-tandem mass spectrometry: simultaneous analysis of amisulpride, and of metamfetamine and amfetamine in serum/plasma. Biomedical chromatography : BMC. 2011 Aug; 25(8):867-72. doi: 10.1002/bmc.1530. [PMID: 21058410]
  • Anna Dietrich-Muszalska, Beata Olas, Bogdan Kontek, Jolanta Rabe-Jabłońska. Beta-glucan from Saccharomyces cerevisiae reduces plasma lipid peroxidation induced by haloperidol. International journal of biological macromolecules. 2011 Jul; 49(1):113-6. doi: 10.1016/j.ijbiomac.2011.03.007. [PMID: 21421004]
  • Ramakotaiah Mogili, Kanchanamala Kanala, Balasekhara Reddy Challa, Babu Rao Chandu, Chandrasekhar Kottapalli Bannoth. Development and validation of amisulpride in human plasma by HPLC coupled with tandem mass spectrometry and its application to a pharmacokinetic study. Scientia pharmaceutica. 2011 Jul; 79(3):583-99. doi: 10.3797/scipharm.1105-12. [PMID: 21886905]
  • Stephanie Teoh, Kenneth F Ilett, L Peter Hackett, Rolland Kohan. Estimation of rac-amisulpride transfer into milk and of infant dose via milk during its use in a lactating woman with bipolar disorder and schizophrenia. Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine. 2011 Apr; 6(2):85-8. doi: 10.1089/bfm.2010.0016. [PMID: 20925494]
  • Chih-Ken Chen, Yu-Shu Huang, Shao-Chun Ree, Cheng-Cheng Hsiao. Differential add-on effects of aripiprazole in resolving hyperprolactinemia induced by risperidone in comparison to benzamide antipsychotics. Progress in neuro-psychopharmacology & biological psychiatry. 2010 Dec; 34(8):1495-9. doi: 10.1016/j.pnpbp.2010.08.012. [PMID: 20732372]
  • Kenneth F Ilett, Felice Watt, L Peter Hackett, Rolland Kohan, Stephanie Teoh. Assessment of infant dose through milk in a lactating woman taking amisulpride and desvenlafaxine for treatment-resistant depression. Therapeutic drug monitoring. 2010 Dec; 32(6):704-7. doi: 10.1097/ftd.0b013e3181f88f70. [PMID: 20926994]
  • Susanne Englisch, Frank Enning, Martin Grosshans, Lars Marquardt, Robert Waltereit, Mathias Zink. Quetiapine combined with amisulpride in schizophrenic patients with insufficient responses to quetiapine monotherapy. Clinical neuropharmacology. 2010 Sep; 33(5):227-9. doi: 10.1097/wnf.0b013e3181f0f013. [PMID: 20838213]
  • Anna Dietrich-Muszalska, Beata Olas. Inhibitory effects of polyphenol compounds on lipid peroxidation caused by antipsychotics (haloperidol and amisulpride) in human plasma in vitro. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry. 2010 Mar; 11(2 Pt 2):276-81. doi: 10.1080/15622970902718790. [PMID: 19225991]
  • Emmanouil N Rizos, Athanasia Papadopoulou, Efstathios Laskos, Panagiota G Michalopoulou, Anastasia Kastania, Dimitrios Vasilopoulos, Konstantinos Katsafouros, Lefteris Lykouras. Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry. 2010 Mar; 11(2 Pt 2):251-5. doi: 10.3109/15622970802182733. [PMID: 20218789]
  • A Sparshatt, D Taylor, M X Patel, S Kapur. Amisulpride - dose, plasma concentration, occupancy and response: implications for therapeutic drug monitoring. Acta psychiatrica Scandinavica. 2009 Dec; 120(6):416-28. doi: 10.1111/j.1600-0447.2009.01429.x. [PMID: 19573049]
  • Chris M Dodds, Luke Clark, Anja Dove, Ralf Regenthal, Frank Baumann, Ed Bullmore, Trevor W Robbins, Ulrich Müller. The dopamine D2 receptor antagonist sulpiride modulates striatal BOLD signal during the manipulation of information in working memory. Psychopharmacology. 2009 Nov; 207(1):35-45. doi: 10.1007/s00213-009-1634-0. [PMID: 19672580]
  • Matthias J Müller, F X Eich, B Regenbogen, J Sachse, S Härtter, C Hiemke. Amisulpride doses and plasma levels in different age groups of patients with schizophrenia or schizoaffective disorder. Journal of psychopharmacology (Oxford, England). 2009 May; 23(3):278-86. doi: 10.1177/0269881108089806. [PMID: 18562411]
  • Ayan Das, Uttam Bhaumik, Uday S Chakrabarty, Amlan Kanti Sarkar, Animesh Ghosh, Anirbandeep Bose, Bappaditya Chatterjee, Tapan K Pal. Comparative bioavailability study of amisulpride tablets in healthy Indian volunteers. Arzneimittel-Forschung. 2009; 59(4):166-70. doi: 10.1055/s-0031-1296381. [PMID: 19517892]
  • Ma Soledad García, Joaquín A Ortuño, Ma Isabel Albero, Mustafa Salem Abuherba. Development of membrane selective electrode for determination of the antipsychotic sulpiride in pharmaceuticals and urine. Sensors (Basel, Switzerland). 2009; 9(6):4309-22. doi: 10.3390/s90604309. [PMID: 22408528]
  • Ramakrishna Nirogi, Gopinadh Bhyrapuneni, Vishwottam Kandikere, Koteshwara Mudigonda, Devender Ajjala, Ramakrishna Suraneni, K Mukkanti. Liquid chromatography tandem mass spectrometry method for the quantification of amisulpride with LLOQ of 100 pg/mL using 100 microL of plasma. Biomedical chromatography : BMC. 2008 Dec; 22(12):1424-33. doi: 10.1002/bmc.1076. [PMID: 18655221]
  • Béla Kiss, István Laszlovszky, Attila Horváth, Zsolt Némethy, Eva Schmidt, Gyula Bugovics, Károly Fazekas, István Gyertyán, Eva Agai-Csongor, György Domány, Zsolt Szombathelyi. Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: I. neurochemical characterisation of RG-15. Naunyn-Schmiedeberg's archives of pharmacology. 2008 Nov; 378(5):515-28. doi: 10.1007/s00210-008-0308-5. [PMID: 18551280]
  • Sridhar Natesan, Greg E Reckless, Karren B L Barlow, José N Nobrega, Shitij Kapur. Amisulpride the 'atypical' atypical antipsychotic--comparison to haloperidol, risperidone and clozapine. Schizophrenia research. 2008 Oct; 105(1-3):224-35. doi: 10.1016/j.schres.2008.07.005. [PMID: 18710798]
  • E M Meisenzahl, G Schmitt, G Gründer, S Dresel, T Frodl, C la Fougère, J Scheuerecker, M Schwarz, R Boerner, J Stauss, K Hahn, H-J Möller. Striatal D2/D3 receptor occupancy, clinical response and side effects with amisulpride: an iodine-123-iodobenzamide SPET study. Pharmacopsychiatry. 2008 Sep; 41(5):169-75. doi: 10.1055/s-2008-1076727. [PMID: 18763218]
  • Luca Pani, José M Villagrán, Vassilis P Kontaxakis, Köksal Alptekin. Practical issues with amisulpride in the management of patients with schizophrenia. Clinical drug investigation. 2008; 28(8):465-77. doi: 10.2165/00044011-200828080-00001. [PMID: 18598092]
  • Jaromír Svestka, Oldrich Synek, Jana Tomanová, Irena Rodáková, Andrea Cejpková. Differences in the effect of second-generation antipsychotics on prolactinaemia: six weeks open-label trial in female in-patients. Neuro endocrinology letters. 2007 Dec; 28(6):881-8. doi: NULL. [PMID: 18063941]
  • Matthias J Müller, Boris Regenbogen, Sebastian Härtter, Franz X Eich, Christoph Hiemke. Therapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophrenia. Journal of psychiatric research. 2007 Oct; 41(8):673-9. doi: 10.1016/j.jpsychires.2005.10.003. [PMID: 16324716]
  • Niels Bergemann, Fatima Abu-Tair, Kai R Kress, Peter Parzer, Jürgen Kopitz. Increase in plasma concentration of amisulpride after addition of concomitant lithium. Journal of clinical psychopharmacology. 2007 Oct; 27(5):546-9. doi: 10.1097/jcp.0b013e31814f4dbb. [PMID: 17873709]
  • Harumasa Takano, Hidehiko Takahashi, Hiroshi Ito, Tetsuya Suhara. [Molecular imaging in the drug development of psychotropics using positron emission tomography]. Brain and nerve = Shinkei kenkyu no shinpo. 2007 Mar; 59(3):215-20. doi: . [PMID: 17370647]
  • Thomas Paparrigopoulos, John Liappas, Elias Tzavellas, Iraklis Mourikis, Constantin Soldatos. Amisulpride-induced hyperprolactinemia is reversible following discontinuation. Progress in neuro-psychopharmacology & biological psychiatry. 2007 Jan; 31(1):92-6. doi: 10.1016/j.pnpbp.2006.07.006. [PMID: 16938372]
  • Maria A Rettenbacher, Christoph Ebenbichler, Alex Hofer, Georg Kemmler, Susanne Baumgartner, Monika Edlinger, Martina Hummer, Monika Lechleitner, W Wolfgang Fleischhacker. Early changes of plasma lipids during treatment with atypical antipsychotics. International clinical psychopharmacology. 2006 Nov; 21(6):369-72. doi: 10.1097/01.yic.0000224786.75664.3b. [PMID: 17012984]
  • U Schmitt, A Abou El-Ela, L J Guo, H Glavinas, P Krajcsi, J M Baron, C Tillmann, C Hiemke, P Langguth, S Härtter. Cyclosporine A (CsA) affects the pharmacodynamics and pharmacokinetics of the atypical antipsychotic amisulpride probably via inhibition of P-glycoprotein (P-gp). Journal of neural transmission (Vienna, Austria : 1996). 2006 Jul; 113(7):787-801. doi: 10.1007/s00702-005-0367-4. [PMID: 16252067]
  • M J Müller, B Regenbogen, J Sachse, F X Eich, S Härtter, C Hiemke. Gender aspects in the clinical treatment of schizophrenic inpatients with amisulpride: a therapeutic drug monitoring study. Pharmacopsychiatry. 2006 Mar; 39(2):41-6. doi: 10.1055/s-2006-931540. [PMID: 16555163]
  • M H Gschwend, P Arnold, J Ring, W Martin. Selective and sensitive determination of amisulpride in human plasma by liquid chromatography-tandem mass spectrometry with positive electrospray ionisation and multiple reaction monitoring. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2006 Feb; 831(1-2):132-9. doi: 10.1016/j.jchromb.2005.11.042. [PMID: 16386474]
  • Niels Bergemann, Kai R Kress, Alex Frick, Jürgen Kopitz. Amisulpride has no effect on plasma clozapine concentrations. Journal of clinical psychopharmacology. 2005 Oct; 25(5):494-7. doi: 10.1097/01.jcp.0000178418.68050.0d. [PMID: 16160629]
  • Christian la Fougère, Eva Meisenzahl, Gisela Schmitt, Jan Stauss, Thomas Frodl, Klaus Tatsch, Klaus Hahn, Hans-Jürgen Möller, Stefan Dresel. D2 receptor occupancy during high- and low-dose therapy with the atypical antipsychotic amisulpride: a 123I-iodobenzamide SPECT study. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2005 Jun; 46(6):1028-33. doi: NULL. [PMID: 15937316]
  • Karine Titier, Pierre-Olivier Girodet, Hélène Verdoux, Mathieu Molimard, Bernard Bégaud, Wilhelm Haverkamp, Malcolm Lader, Nicholas Moore. Atypical antipsychotics: from potassium channels to torsade de pointes and sudden death. Drug safety. 2005; 28(1):35-51. doi: 10.2165/00002018-200528010-00003. [PMID: 15649104]
  • Ingo Vernaleken, Thomas Siessmeier, Hans-Georg Buchholz, Sebastian Härtter, Christoph Hiemke, Peter Stoeter, Frank Rösch, Peter Bartenstein, Gerhard Gründer. High striatal occupancy of D2-like dopamine receptors by amisulpride in the brain of patients with schizophrenia. The international journal of neuropsychopharmacology. 2004 Dec; 7(4):421-30. doi: 10.1017/s1461145704004353. [PMID: 15683553]
  • Miloslav Kopecek, Martin Bares, Jirí Svarc, Colleen Dockery, Jirí Horácek. Hyperprolactinemia after low dose of amisulpride. Neuro endocrinology letters. 2004 Dec; 25(6):419-22. doi: NULL. [PMID: 15665803]
  • Rodrigo A Bressan, Kjell Erlandsson, Edgar P Spencer, Peter J Ell, Lyn S Pilowsky. Prolactinemia is uncoupled from central D2/D3 dopamine receptor occupancy in amisulpride treated patients. Psychopharmacology. 2004 Sep; 175(3):367-73. doi: 10.1007/s00213-004-1826-6. [PMID: 14997280]
  • Amal Abou El Ela, Sebastian Härtter, Ulrich Schmitt, Christoph Hiemke, Hildegard Spahn-Langguth, Peter Langguth. Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds--implications for pharmacokinetics of selected substrates. The Journal of pharmacy and pharmacology. 2004 Aug; 56(8):967-75. doi: 10.1211/0022357043969. [PMID: 15285840]
  • N Bergemann, J Kopitz, K R Kress, A Frick. Plasma amisulpride levels in schizophrenia or schizoaffective disorder. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 2004 May; 14(3):245-50. doi: 10.1016/j.euroneuro.2003.09.001. [PMID: 15056484]
  • Kate McKeage, Greg L Plosker. Amisulpride: a review of its use in the management of schizophrenia. CNS drugs. 2004; 18(13):933-56. doi: 10.2165/00023210-200418130-00007. [PMID: 15521794]
  • Mathias Zink, Udo Knopf, Fritz A Henn, Johannes Thome. Combination of clozapine and amisulpride in treatment-resistant schizophrenia--case reports and review of the literature. Pharmacopsychiatry. 2004 Jan; 37(1):26-31. doi: 10.1055/s-2004-815471. [PMID: 14750045]
  • F Péhourcq, S Ouariki, B Bégaud. Rapid high-performance liquid chromatographic measurement of amisulpride in human plasma: application to manage acute intoxication. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2003 Jun; 789(1):101-5. doi: 10.1016/s1570-0232(03)00045-x. [PMID: 12726848]
  • Muriel Canal, Eric Legangneux, Jan Jaap van Lier, Andre Antonius van Vliet, Catherine Coulouvrat. Lack of effect of amisulpride on the pharmacokinetics and safety of lithium. The international journal of neuropsychopharmacology. 2003 Jun; 6(2):103-9. doi: 10.1017/s1461145703003377. [PMID: 12890302]
  • Ryoko Chiba, Ayako Ogasawara, Teppei Kubo, Hiroyuki Yamazaki, Masuo Umino, Yoichi Ishizuka. Direct determination of benzamides in serum by column-switching high-performance liquid chromatography. Analytical sciences : the international journal of the Japan Society for Analytical Chemistry. 2003 May; 19(5):785-9. doi: 10.2116/analsci.19.785. [PMID: 12769385]
  • Mirijam Fric, Gerd Laux. [Plasma prolactin level and incidence of adverse endocrinologic effects during therapy with atypical neuroleptics]. Psychiatrische Praxis. 2003 May; 30 Suppl 2(?):S97-101. doi: NULL. [PMID: 14509051]
  • Julia Sachse, Sebastian Härtter, Harald Weigmann, Christoph Hiemke. Automated determination of amisulpride by liquid chromatography with column switching and spectrophotometric detection. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2003 Feb; 784(2):405-10. doi: 10.1016/s1570-0232(02)00808-5. [PMID: 12505788]
  • Giorgio Marchese, Stefania Ruiu, Paola Casti, Pierluigi Saba, Gian Luigi Gessa, Luca Pani. Effect of the amisulpride isomers on rat prolactinemia. European journal of pharmacology. 2002 Jul; 448(2-3):263-6. doi: 10.1016/s0014-2999(02)01990-8. [PMID: 12144950]
  • Giorgio Marchese, Stefania Ruiu, Paola Casti, Francesco Bartholini, Pierluigi Saba, Gian Luigi Gessa, Luca Pani. Carmoxirole is able to reduce amisulpride-induced hyperprolactinemia without affecting its central effect. European journal of pharmacology. 2002 Jun; 447(1):109-14. doi: 10.1016/s0014-2999(02)01896-4. [PMID: 12106810]
  • R Schlösser, G Gründer, I Anghelescu, A Hillert, S Ewald-Gründer, C Hiemke, O Benkert. Long-term effects of the substituted benzamide derivative amisulpride on baseline and stimulated prolactin levels. Neuropsychobiology. 2002; 46(1):33-40. doi: 10.1159/000063574. [PMID: 12207145]
  • P Rosenzweig, M Canal, A Patat, L Bergougnan, I Zieleniuk, G Bianchetti. A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers. Human psychopharmacology. 2002 Jan; 17(1):1-13. doi: 10.1002/hup.320. [PMID: 12404702]
  • T Someya, K Shimoda, T Muratake, E Nakajima, A Shirai, H Funaoka, T Yashiki, H Ishii, N Sunahara, S Takahashi. Establishment of enzyme immunoassay for measuring serum sultopride levels. Therapeutic drug monitoring. 2001 Jun; 23(3):277-81. doi: 10.1097/00007691-200106000-00016. [PMID: 11360038]
  • X Xiberas, J L Martinot, L Mallet, E Artiges, M Canal, C Loc'h, B Mazière, M L Paillère-Martinot. In vivo extrastriatal and striatal D2 dopamine receptor blockade by amisulpride in schizophrenia. Journal of clinical psychopharmacology. 2001 Apr; 21(2):207-14. doi: 10.1097/00004714-200104000-00013. [PMID: 11270918]
  • S Kapur, G Remington. Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia. Annual review of medicine. 2001; 52(?):503-17. doi: 10.1146/annurev.med.52.1.503. [PMID: 11160792]
  • G Gründer, H Wetzel, R Schlösser, I Anghelescu, A Hillert, K Lange, C Hiemke, O Benkert. Neuroendocrine response to antipsychotics: effects of drug type and gender. Biological psychiatry. 1999 Jan; 45(1):89-97. doi: 10.1016/s0006-3223(98)00125-5. [PMID: 9894580]
  • N Jitsufuchi, K Kudo, H Tokunaga, T Imamura. Selective determination of sultopride in human plasma using high-performance liquid chromatography with ultraviolet detection and particle beam mass spectrometry. Journal of chromatography. B, Biomedical sciences and applications. 1997 Mar; 690(1-2):153-9. doi: 10.1016/s0378-4347(96)00423-9. [PMID: 9106039]
  • V Ascalone, M Ripamonti, B Malavasi. Stereospecific determination of amisulpride, a new benzamide derivative, in human plasma and urine by automated solid-phase extraction and liquid chromatography on a chiral column. application to pharmacokinetics. Journal of chromatography. B, Biomedical applications. 1996 Feb; 676(1):95-105. doi: 10.1016/0378-4347(95)00418-1. [PMID: 8852049]
  • B Malavasi, M Locatelli, M Ripamonti, V Ascalone. Determination of amisulpride, a new benzamide derivative, in human plasma and urine by liquid-liquid extraction or solid-phase extraction in combination with high-performance liquid chromatography and fluorescence detection. application to pharmacokinetics. Journal of chromatography. B, Biomedical applications. 1996 Feb; 676(1):107-15. doi: 10.1016/0378-4347(95)00420-3. [PMID: 8852050]